Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Angiogene Incorporated

Antiproliferative Therapeutics Drug Discovery Cardiovascular Diseases Oncology Radio


Contact Details:
1851 Sherbrooke E. Suite 704
Montreal
Quebec
H2K 4L5
United Kingdom
Tel:(514) 596-1111
Fax:(514) 596-1119
Email:
WWW:

www.angiogene.com/




Loading...

Recent Publications by Angiogene Incorporated:

Exploiting the tumor microenvironment in the development of targeted cancer gene therapy.
The future success of cancer gene therapy is critically dependent upon the...
2nd April, 2009
Angiogene Pharmaceuticals Ltd, The Magdalen Centre, Oxford, UK. Cancer Gene Ther. 2009 Mar;16(3):279-90. Epub 2008 Sep 26.
DOI Direct Link
32P-oligodeoxynucleotide-coated coils to prevent arterial recanalization after embolization.
BACKGROUND AND PURPOSE: Endovascular treatment of aneurysms with coils, a...
5th October, 2004
Angiogene Inc., Montreal, Quebec, Canada. AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1062-6.
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Physiological differences between tumor and normal vasculature provide a...
29th January, 2003
Angiogene Pharmaceuticals Ltd., Oxford Science Park, Oxford, United Cancer Res. 2002 Dec 15;62(24):7247-53.
Enhancement of vascular targeting by inhibitors of nitric oxide synthase.
PURPOSE: This study investigates the enhancement of the vascular targeting...
3rd January, 2003
Angiogene Pharmaceuticals Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1532-6.

Angiogene Incorporated Patents:

US Patent No.Title
7608698 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
6339071 Antisense oligonucleotide modulating cyclin E gene expression and therapeutic uses thereof
6423753 Use of colchinol derivatives as vascular damaging agents
6626928 Occlusion device for treating aneurysm and use therefor
6645950 Benzimidazole vascular damaging agents

View more Angiogene Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 486 times since April 2007, the link to the organisation's website has been followed 124 times

Recent Search Terms used to find this page: angiogene | ANGIOGENE | angiogene | angiogene | angiogene inc montreal | angiogene | Angiogene | Angiogene | angiog ne sherbrooke | angiogene | .

Search for more companies in Montreal

Search for more companies in Quebec



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Angiogene Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.